Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

25.51
-0.3250-1.26%
Volume:113.86K
Turnover:2.92M
Market Cap:2.51B
PE:-4.38
High:25.89
Open:25.75
Low:25.35
Close:25.83
52wk High:39.89
52wk Low:18.29
Shares:98.32M
Float Shares:94.49M
Volume Ratio:0.91
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-8.62
PE(LYR):-4.37

Loading ...

Aug 19, 2026

Major Issues Report

Form 8-K - Current report
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 13, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 11, 2026

Major Issues Report

Form 8-K - Current report
Aug 07, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 05, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 31, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Jul 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Major Issues Report

Form 8-K - Current report
May 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]